KalVista Pharmaceuticals, Inc. (KALV)Healthcare | Biotechnology | Framingham, United States | NasdaqGM
20.48 USD
+0.92
(4.703%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 20.70 +0.22 (1.074%) ⇧ (April 17, 2026, 7:57 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:50 p.m. EDT
KalVista Pharmaceuticals (KALV) is currently in a volatile phase, with recent news and trials showing potential for growth. However, the stock's fundamentals are weak, with negative profit margins and a high short ratio, indicating skepticism from investors. The stock has shown some upward momentum, but the lack of dividends and the mixed options activity suggest caution. While the recent positive news may present a buying opportunity for short-term traders, long-term investors should be wary of the company's financial health and the overall market risk. The current price is relatively close to its 52-week high, which could indicate a potential pullback or a continuation of the upward trend. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.114957 |
| AutoTheta | 0.125885 |
| AutoARIMA | 0.131957 |
| AutoETS | 0.131958 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 62.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.120 |
| Excess Kurtosis | -1.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 1.367 |
| Market Cap | 1,049,036,544 |
| Forward P/E | 20.36 |
| Beta | -0.40 |
| Profit Margins | -223.16% |
| Website | https://www.kalvista.com |
As of April 11, 2026, 2:50 p.m. EDT: Options speculators are showing mixed signals. The calls show a concentration around the ATM strike of 20.0 with significant open interest, indicating potential bullish sentiment. However, the puts also have notable open interest at lower strikes, suggesting some bearish positioning. The IV is generally low, which may indicate a lack of conviction in either direction. The recent price action shows some volatility, with a recent dip below the 50-day average, but there are signs of potential momentum as the stock approaches its 52-week high. Overall, the options activity suggests a cautious approach with both bullish and bearish views present.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.7052456 |
| Address1 | 200 Crossing Boulevard |
| All Time High | 129.108 |
| All Time Low | 4.12 |
| Ask | 20.55 |
| Ask Size | 1 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 1,073,720 |
| Average Daily Volume3 Month | 952,685 |
| Average Volume | 952,685 |
| Average Volume10Days | 1,073,720 |
| Beta | -0.399 |
| Bid | 20.43 |
| Bid Size | 1 |
| Board Risk | 6 |
| Book Value | -0.053 |
| City | Framingham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 20.48 |
| Current Ratio | 5.582 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 20.8 |
| Day Low | 19.74 |
| Display Name | KalVista Pharmaceuticals |
| Dividend Date | 1,479,772,800 |
| Earnings Call Timestamp End | 1,762,867,800 |
| Earnings Call Timestamp Start | 1,762,867,800 |
| Earnings Timestamp | 1,774,441,800 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | -164,816,992 |
| Ebitda Margins | -2.23884 |
| Enterprise To Ebitda | -6.268 |
| Enterprise To Revenue | 14.032 |
| Enterprise Value | 1,033,029,504 |
| Eps Current Year | -0.95 |
| Eps Forward | 1.00571 |
| Eps Trailing Twelve Months | -3.94 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 866 553 3269 |
| Fifty Day Average | 17.2666 |
| Fifty Day Average Change | 3.2134 |
| Fifty Day Average Change Percent | 0.18610497 |
| Fifty Two Week Change Percent | 70.52456 |
| Fifty Two Week High | 21.305 |
| Fifty Two Week High Change | -0.82500076 |
| Fifty Two Week High Change Percent | -0.03872334 |
| Fifty Two Week Low | 9.83 |
| Fifty Two Week Low Change | 10.65 |
| Fifty Two Week Low Change Percent | 1.0834181 |
| Fifty Two Week Range | 9.83 - 21.305 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,428,586,200,000 |
| Float Shares | 29,556,399 |
| Forward Eps | 1.00571 |
| Forward P E | 20.363722 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 275 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.25726 |
| Gross Profits | 18,939,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01609 |
| Held Percent Institutions | 1.3464999 |
| Implied Shares Outstanding | 51,222,487 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,479,772,800 |
| Last Split Factor | 1:14 |
| Long Business Summary | KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. |
| Long Name | KalVista Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 1,049,036,544 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_136678928 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -164,286,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,049,548,758 |
| Number Of Analyst Opinions | 9 |
| Open | 19.97 |
| Operating Cashflow | -122,431,504 |
| Operating Margins | -0.21221 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 857 999 0075 |
| Post Market Change | 0.22000122 |
| Post Market Change Percent | 1.0742247 |
| Post Market Price | 20.7 |
| Post Market Time | 1,776,470,276 |
| Previous Close | 19.56 |
| Price Eps Current Year | -21.557894 |
| Price Hint | 2 |
| Price To Book | -386.4151 |
| Price To Sales Trailing12 Months | 14.249923 |
| Profit Margins | -2.2316298 |
| Quick Ratio | 5.431 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.22222 |
| Region | US |
| Regular Market Change | 0.92 |
| Regular Market Change Percent | 4.70348 |
| Regular Market Day High | 20.8 |
| Regular Market Day Low | 19.74 |
| Regular Market Day Range | 19.74 - 20.8 |
| Regular Market Open | 19.97 |
| Regular Market Previous Close | 19.56 |
| Regular Market Price | 20.48 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,088,389 |
| Revenue Per Share | 1.367 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 51,222,487 |
| Shares Percent Shares Out | 0.3975 |
| Shares Short | 20,359,503 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 19,278,799 |
| Short Name | KalVista Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.4465 |
| Short Ratio | 16.72 |
| Source Interval | 15 |
| State | MA |
| Symbol | KALV |
| Target High Price | 42.0 |
| Target Low Price | 22.0 |
| Target Mean Price | 34.33333 |
| Target Median Price | 36.0 |
| Total Cash | 300,214,016 |
| Total Cash Per Share | 5.861 |
| Total Debt | 284,207,008 |
| Total Revenue | 73,617,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.94 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.714125 |
| Two Hundred Day Average Change | 5.765875 |
| Two Hundred Day Average Change Percent | 0.39185986 |
| Type Disp | Equity |
| Volume | 1,088,389 |
| Website | https://www.kalvista.com |
| Zip | 1,702 |